Report Detail
Global mRNA Cancer Vaccines and Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM3040612 |
- 28 February, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Other
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
According to this study, over the next five years the mRNA Cancer Vaccines and Therapeutics market will register a 24.3% CAGR in terms of revenue, the global market size will reach US$ 400 million by 2024, from US$ 110 million in 2019. In particular, this report presents the global revenue market share of key companies in mRNA Cancer Vaccines and Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of mRNA Cancer Vaccines and Therapeutics market by product type, application, key companies and key regions.
This study considers the mRNA Cancer Vaccines and Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Adeno Carcinomas
Mucinous Carcinomas
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Infectious Disease
Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global mRNA Cancer Vaccines and Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of mRNA Cancer Vaccines and Therapeutics market by identifying its various subsegments.
Focuses on the key global mRNA Cancer Vaccines and Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the mRNA Cancer Vaccines and Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of mRNA Cancer Vaccines and Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global mRNA Cancer Vaccines and Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size 2014-2024
- 2.1.2 mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Region
- 2.2 mRNA Cancer Vaccines and Therapeutics Segment by Type
- 2.2.1 Adeno Carcinomas
- 2.2.2 Mucinous Carcinomas
- 2.2.3 Adenosquamous Carcinomas
- 2.3 mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 2.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 mRNA Cancer Vaccines and Therapeutics Segment by Application
- 2.4.1 Infectious Disease
- 2.4.2 Cancer
- 2.4.3 Other
- 2.5 mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 2.5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global mRNA Cancer Vaccines and Therapeutics by Players
- 3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Players
- 3.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global mRNA Cancer Vaccines and Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 mRNA Cancer Vaccines and Therapeutics by Regions
- 4.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions
- 4.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size Growth
- 4.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size Growth
- 4.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth
- 4.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth
5 Americas
- 5.1 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Countries
- 5.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 5.3 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Countries
- 6.2 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 6.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe mRNA Cancer Vaccines and Therapeutics by Countries
- 7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics by Countries
- 8.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 8.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global mRNA Cancer Vaccines and Therapeutics Market Forecast
- 10.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions
- 10.2.1 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global mRNA Cancer Vaccines and Therapeutics Forecast by Type
- 10.8 Global mRNA Cancer Vaccines and Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 Moderna Therapeutics
- 11.1.1 Company Details
- 11.1.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Moderna Therapeutics News
- 11.2 CureVac
- 11.2.1 Company Details
- 11.2.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 CureVac News
- 11.3 Translate Bio
- 11.3.1 Company Details
- 11.3.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Translate Bio News
- 11.4 BioNTech
- 11.4.1 Company Details
- 11.4.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 BioNTech News
- 11.5 Sangamo Therapeutics
- 11.5.1 Company Details
- 11.5.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Sangamo Therapeutics News
- 11.6 Argos Therapeutics
- 11.6.1 Company Details
- 11.6.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Argos Therapeutics News
- 11.7 In-Cell-Art
- 11.7.1 Company Details
- 11.7.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 In-Cell-Art News
- 11.8 eTheRNA
- 11.8.1 Company Details
- 11.8.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 eTheRNA News
- 11.9 Ethris
- 11.9.1 Company Details
- 11.9.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Ethris News
- 11.10 Tiba Biotechnology
- 11.10.1 Company Details
- 11.10.2 mRNA Cancer Vaccines and Therapeutics Product Offered
- 11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Tiba Biotechnology News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on mRNA Cancer Vaccines and Therapeutics . Industry analysis & Market Report on mRNA Cancer Vaccines and Therapeutics is a syndicated market report, published as Global mRNA Cancer Vaccines and Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of mRNA Cancer Vaccines and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
